Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-28T10:38:57.445Z Has data issue: false hasContentIssue false
  • English
  • Français

Role of Combination Antibiogram in Empirical Treatment of Infection Due to Multidrug-Resistant Acinetobacter baumannii

Published online by Cambridge University Press:  02 January 2015

Anucha Apisarnthanarak  and
Linda M. Mundy
Anucha Apisarnthanarak*
Affiliation:
Division of Infectious Diseases, Faculty of Medicine, Thammasat University Hospital, Pratumthani, Thailand
Linda M. Mundy
Affiliation:
St. Louis University School of Public Health, St. Louis, Missouri
*
Division of Infectious Diseases Faculty of Medicine Thammasat University Hospital Pratumthani, Thailand12120 ([email protected])
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 29 , Issue 7 , July 2008 , pp. 678 - 679
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

References

1.Mizuta, M, Linkin, DR, Nachamkin, I, et al. Identification of optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection: potential role of a combination antibiogram. Infect Control Hosp Epidemiol 2006;27:413–415.Google Scholar
2.Abbo, A, Navon-Venezia, S, Hammer-Muntz, O, Krichali, T, Siegman-Igra, Y, Carmeli, Y. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 2005;11:22–29.Google Scholar
3.National Antimicrobial Resistant Surveillance Center. Annual epidemiology and surveillance report, 2007. Available at: http://narst.dmsc.moph.go.fh/. Accessed January 1,2008.Google Scholar
4.Abbo, A, Carmeli, Y, Navon-Venezia, S, Siegman-Igra, Y, Schwaber, MJ. Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur J Clin Microbiol Infect Dis 2007;26:793–800.Google Scholar
5.Lee, NY, Lee, HC, Ko, NY, et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007;28:713–719.Google Scholar
6.National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution: antimicrobial susceptibility testing for bacteria that grow aerobically. 4th ed. NCCLS document. Villanova, PA: NCCLS; 1997:M7–A3.Google Scholar
7.Falagas, ME, Kasiakou, SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005;40:1333–1341.Google Scholar